Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

AstraZeneca launch redesigned NebuChamber

  • Comment

Following a recall of the NebuChamber spacer device in April 2009, AstraZeneca has announced that a re-designed NebuChamber mouthpiece and facemask is available to order.

All patients who are receiving Pulmicort (budesonide) CFC-free Inhaler and require the use of a spacer, should now receive the new NebuChamber as this is the only spacer device specifically licensed for use with Pulmicort.

In April 2009, AstraZeneca recalled all stocks of NebuChamber spacers because a slight change in the dimensions of the spacer aperture (at the mouthpiece end) meant that it was possible for the mouthpiece to be fitted to the spacer in the wrong direction. As a result, patients would have been unable to inhale the product because the mouthpiece contains a one-way valve.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.